Loading company…
Valar Labs develops AI software to help oncologists assess patients and inform cancer treatment decisions.
Based in California, Valar Labs provides an AI platform for oncologists to evaluate patient characteristics and inform treatment decisions. Its clients include academic medical centers and community oncologists. Founded in 2021, the company raised USD 22 million in Series A funding in May 2024, co-led by Data Collective and Andreessen Horowitz, with participation from Pear VC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in